Who
Murat Kalayoglu
10% owner
Company insider
Files Form 4 as: Director and 10% owner, Cartesian Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Nov 2023
- Last trade
- 2 Apr 2026
- Last filed
- 6 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 6 Apr 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | —758,001 | filing |
| 2 Apr 2026filed 6 Apr 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —22,740.03 | filing |
| 2 Apr 2026filed 6 Apr 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —22,740.03 | filing |
| 2 Apr 2026filed 6 Apr 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | —758,001 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 11 Oct 2024filed 15 Oct 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —45,551.19 | filing |
| 11 Oct 2024filed 15 Oct 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,518,373 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —14,755.61 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —87,802.95 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | —491,853 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | —2,926,764 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —228,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —178,000 at $0.00 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,755.61 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —189,136.77 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.